by Scott Ford | Feb 2, 2024 | Blog
Truthfully, I just made up that title. There is really no discipline known as “cancer tissue management science” or “biospecimen management science”. At SpeCicare, our team is investigating this space because we believe that living tissue is better for most clinical...
by Scott Ford | Jan 24, 2024 | Blog
This is one of the first papers on Biospecimen Management for the Community pathologist and therefore the community patient. In 2012, SpeciCare’s Chief of Pathology David Booker convened a group of academic pathologists including those from Mass General, Duke,...
by Scott Ford | Jan 24, 2024 | Blog
Why should any cancer patient question the “standard of care?” The standard of care is the thoroughly vetted and accepted way of providing cancer care. Most of the time, it provides the best opportunities for cure and survival. And, if this is so, is...
by Scott Ford | Jan 17, 2024 | Blog
Melanoma tissue should be collected, frozen, and saved for potential future diagnosis and therapy, if the melanoma is advanced, recurrent, or metastatic. Frozen tissues provide the best specimen to enable the search for either the mutations that drive the cancer or...
by Scott Ford | Dec 15, 2023 | Blog
Cancer screening is an essential step in early cancer detection and can provide patients with one of the most critical aspects of treatment – time. When to get screened for cancer depends on a multitude of factors, including age, the type of cancer, personal health...
by Scott Ford | Dec 6, 2023 | Blog
The rate of cancer deaths has been steadily declining in the U.S. over the past thirty years. Today, the risk of cancer death is 33% lower than it was in 1991. There are a lot of reasons for this decline. Research has led to more effective treatments. Smoking rates...
Recent Comments